These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15254743)

  • 1. Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells.
    Zhong X; Li X; Wang G; Zhu Y; Hu G; Zhao J; Neace C; Ding H; Reed E; Li QQ
    Int J Oncol; 2004 Aug; 25(2):445-51. PubMed ID: 15254743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.
    Park SH; Lee JH; Lee GB; Byun HJ; Kim BR; Park CY; Kim HB; Rho SB
    Cell Signal; 2012 Mar; 24(3):726-33. PubMed ID: 22142513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SU5416 sensitizes ovarian cancer cells to cisplatin through inhibition of nucleotide excision repair.
    Zhong X; Li QQ; Reed E
    Cell Mol Life Sci; 2003 Apr; 60(4):794-802. PubMed ID: 12785726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT/Enhancer-binding protein-homologous protein sensitizes to SU5416 by modulating p21 and PI3K/Akt signal pathway in FRO anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Horm Metab Res; 2013 Jan; 45(1):9-14. PubMed ID: 22918703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation.
    Ning S; Laird D; Cherrington JM; Knox SJ
    Radiat Res; 2002 Jan; 157(1):45-51. PubMed ID: 11754641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway.
    Zhong XS; Zheng JZ; Reed E; Jiang BH
    Biochem Biophys Res Commun; 2004 Nov; 324(2):471-80. PubMed ID: 15474452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase.
    Li X; Wang G; Zhao J; Ding H; Cunningham C; Chen F; Flynn DC; Reed E; Li QQ
    Cell Mol Life Sci; 2005 Apr; 62(7-8):894-904. PubMed ID: 15868412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkaloids from Stephania venosa as Chemo-Sensitizers in SKOV3 Ovarian Cancer Cells via Akt/NF-κB Signaling.
    Mon MT; Yodkeeree S; Punfa W; Pompimon W; Limtrakul P
    Chem Pharm Bull (Tokyo); 2018; 66(2):162-169. PubMed ID: 29386467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase.
    DeHaan RD; Yazlovitskaya EM; Persons DL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):383-8. PubMed ID: 11761456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
    Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
    Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression.
    Li D; Williams JI; Pietras RJ
    Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T; Yang JL; Price JO; Arteaga CL
    Exp Cell Res; 1998 Dec; 245(2):350-9. PubMed ID: 9851876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line.
    Zhang K; Wang X; Wang H
    Mol Med Rep; 2014 Oct; 10(4):2065-72. PubMed ID: 25109654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of Bcl-2 on beta-amyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation.
    Song YS; Park HJ; Kim SY; Lee SH; Yoo HS; Lee HS; Lee MK; Oh KW; Kang SK; Lee SE; Hong JT
    Neurosci Res; 2004 May; 49(1):69-80. PubMed ID: 15099705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.